Cellular consequences of inositol depletion

Biochemical Society Transactions

Volumn 37, Issue 5, 2009, Pages 1099-1103

  Deranieh, Rania M ^a   Greenberg, Miriam L ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Inositol depletion; Inositol phosphate; Myo inositol; Phosphoinositide; Valproic acid

Indexed keywords

CARBAMAZEPINE; GLYCOGEN SYNTHASE KINASE 3; INOSITOL PHOSPHATE; LITHIUM SALT; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL DIACYLGLYCEROL LYASE; VALPROIC ACID;

BIPOLAR DISORDER; CELL FUNCTION; CONFERENCE PAPER; DEPHOSPHORYLATION; DEPLETION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; INTRACELLULAR TRANSPORT; LIPOGENESIS; NERVE CELL PLASTICITY; NONHUMAN; PATHOPHYSIOLOGY; PHOSPHOINOSITIDE METABOLISM; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

BIPOLAR DISORDER; DIGLYCERIDES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INOSITOL; INOSITOL PHOSPHATES; LITHIUM COMPOUNDS; MITOCHONDRIA; PHOSPHATIDYLINOSITOLS; SIGNAL TRANSDUCTION;

EID: 70350169737     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0371099     Document Type: Conference Paper

References (58)

1. Berridge, M.J. and Irvine, R.F. (1989) Inositol phosphates and cell signalling. Nature 341, 197-205
2. Berridge, M.J., Downes, C.P. and Hanley, M.R. (1989) Neural and developmental actions of lithium: a unifying hypothesis. Cell 59, 411-419
3. Silverstone, P.H., McGrath, B.M. and Kim, H. (2005) Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings. Bipolar Disord. 7, 1-10
4. McLaurin, J., Franklin, T., Chakrabartty, A. and Fraser, P.E. (1998) Phosphatidylinositol and inositol involvement in Alzheimer amyloid-β fibril growth and arrest. J. Mol. Biol. 278, 183-194
5. Whiting, P.H., Palmano, K.P. and Hawthorne, J.N. (1979) Enzymes of myo-inositol and inositol lipid metabolism in rats with streptozotocin-induced diabetes. Biochem. J. 179, 549-553
6. Brex, P.A., Gomez-Anson, B., Parker, G.J., Molyneux, P.D., Miszkiel, K.A., Barker, G.J., MacManus, D.G., Davie, C.A., Plant, G.T. and Miller, D.H. (1999) Proton MR spectroscopy in clinically isolated syndromes suggestive of multiple sclerosis. J. Neurol. Sci. 166, 16-22
7. Shaldubina, A., Stahl, Z., Furszpan, M., Regenold, W.T., Shapiro, J., Belmaker, R.H. and Bersudsky, Y. (2006) Inositol deficiency diet and lithium effects. Bipolar Disord. 8, 152-159
8. Shimon, H., Agam, G., Belmaker, R.H., Hyde, T.M. and Kleinman, J.E. (1997) Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am. J. Psychiatry. 154, 1148-1150
9. Loewus, M.W., Loewus, F.A., Brillinger, G.U., Otsuka, H. and Floss, H.G. (1980) Stereochemistry of the myo-inositol-1-phosphate synthase reaction. J. Biol. Chem. 255, 11710-11712
10. Irvine, R.F. and Schell, M.J. (2001) Back in the water: the return of the inositol phosphates. Nat. Rev. Mol. Cell Biol. 2, 327-338
11. van Calker, D. and Belmaker, R.H. (2000) The high affinity inositol transport system: implications for the pathophysiology and treatment of bipolar disorder. Bipolar Disord. 2, 102-107
12. Harwood, A.J. (2005) Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol. Psychiatry 10, 117-126
13. Carman, G.M. and Henry, S.A. (1999) Phospholipid biosynthesis in the yeast Saccharomyces cerevisiae and interrelationship with other metabolic processes. Prog. Lipid Res. 38, 361-399
14. Greenberg, M.L. and Lopes, J.M. (1996) Genetic regulation of phospholipid biosynthesis in Saccharomyces cerevisiae. Microbiol. Rev. 60, 1-20
15. Shears, S.B. (1989) The pathway of myo-inositol 1,3,4-trisphosphate phosphorylation in liver: identification of myo-inositol 1,3,4-trisphosphate 6-kinase, myo-inositol 1,3,4-trisphosphate 5-kinase, and myo-inositol 1,3,4,6-tetrakisphosphate 5-kinase. J. Biol. Chem. 264, 19879-19886
16. Murray, M. and Greenberg, M.L. (2000) Expression of yeast INM1 encoding inositol monophosphatase is regulated by inositol, carbon source and growth stage and is decreased by lithium and valproate. Mol. Microbiol. 36, 651-661
17. Ju, S., Shaltiel, G., Shamir, A., Agam, G. and Greenberg, M.L. (2004) Human 1-d-myo-inositol-3-phosphate synthase is functional in yeast. J. Biol. Chem. 279, 21759-21765
18. Hallcher, L.M. and Sherman, W.R. (1980) The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 255, 10896-10901
19. Inhorn, R.C., Bansal, V.S. and Majerus, P.W. (1987) Pathway for inositol 1,3,4-trisphosphate and 1,4-bisphosphate metabolism. Proc. Natl. Acad. Sci. U.S.A. 84, 2170-2174
20. Shaltiel, G., Shamir, A., Shapiro, J., Ding, D., Dalton, E., Bialer, M., Harwood, A.J., Belmaker, R.H., Greenberg, M.L. and Agam, G. (2004) Valproate decreases inositol biosynthesis. Biol. Psychiatry 56, 868-874
21. Vaden, D.L., Ding, D., Peterson, B. and Greenberg, M.L. (2001) Lithium and valproate decrease inositol mass and increase expression of the yeast INO1 and INO2 genes for inositol biosynthesis. J. Biol. Chem. 276, 15466-15471
22. Ju, S. and Greenberg, M.L. (2003) Valproate disrupts regulation of inositol responsive genes and alters regulation of phospholipid biosynthesis. Mol. Microbiol. 49, 1595-1603
23. Tokuoka, S.M., Saiardi, A. and Nurrish, S.J. (2008) The mood stabilizer valproate inhibits both inositol- and diacylglycerol-signaling pathways in Caenorhabditis elegans. Mol. Biol. Cell 19, 2241-2250
24. +/myo-inositol cotransporter leads to brain myo-inositol depletion and central apnea. J. Biol. Chem. 278, 18297-18302
25. Berry, G.T., Buccafusca, R., Greer, J.J. and Eccleston, E. (2004) Phosphoinositide deficiency due to inositol depletion is not a mechanism of lithium action in brain. Mol. Genet. Metab. 82, 87-92
26. Klein, P.S. and Melton, D.A. (1996) A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U.S.A. 93, 8455-8459
27. Jope, R.S. (2003) Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol. Sci. 24, 441-443
28. Gould, T.D. and Manji, H.K. (2005) Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsychopharmacology 30, 1223-1237
29. Di Daniel, E., Cheng, L., Maycox, P.R. and Mudge, A.W. (2006) The common inositol-reversible effect of mood stabilizers on neurons does not involve GSK3 inhibition, myo-inositol-1-phosphate synthase or the sodium-dependent myo-inositol transporters. Mol. Cell. Neurosci. 32, 27-36
30. Azab, A.N., He, Q., Ju, S., Li, G. and Greenberg, M.L. (2007) Glycogen synthase kinase-3 is required for optimal de novo synthesis of inositol. Mol. Microbiol. 63, 1248-1258
31. Chang, H.J., Jesch, S.A., Gaspar, M.L. and Henry, S.A. (2004) Role of the unfolded protein response pathway in secretory stress and regulation of INO1 expression in Saccharomyces cerevisiae. Genetics 168, 1899-1913
32. Nunez, L.R. and Henry, S.A. (2006) Regulation of 1d-myo-inositol-3-phosphate synthase in yeast. Subcell. Biochem. 39, 135-156
33. Simonsen, A., Wurmser, A.E., Emr, S.D. and Stenmark, H. (2001) The role of phosphoinositides in membrane transport. Curr. Opin. Cell Biol. 13, 485-492
34. Jesch, S.A., Zhao, X., Wells, M.T. and Henry, S.A. (2005) Genome-wide analysis reveals inositol, not choline, as the major effector of Ino2p-Ino4p and unfolded protein response target gene expression in yeast. J. Biol. Chem. 280, 9106-9118
35. Di Paolo, G. and De Camilli, P. (2006) Phosphoinositides in cell regulation and membrane dynamics. Nature 443, 651-657
36. Michell, R.H., Heath, V.L., Lemmon, M.A. and Dove, S.K. (2006) Phosphatidylinositol 3,5-bisphosphate: metabolism and cellular functions. Trends Biochem. Sci. 31, 52-63
37. Sbrissa, D., Ikonomov, O.C., Fu, Z., Ijuin, T., Gruenberg, J., Takenawa, T. and Shisheva, A. (2007) Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport: novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex. J. Biol. Chem. 282, 23878-23891
38. Dowler, S., Montalvo, L., Cantrell, D., Morrice, N. and Alessi, D.R. (2000) Phosphoinositide 3-kinase-dependent phosphorylation of the dual adaptor for phosphotyrosine and 3-phosphoinositides by the Src family of tyrosine kinase. Biochem. J. 349, 605-610
39. Mora, A., Komander, D., van Aalten, D.M. and Alessi, D.R. (2004) PDK1, the master regulator of AGC kinase signal transduction. Semin. Cell Dev. Biol. 15, 161-170
40. 2+ signalling. Philos. Trans. R. Soc. London Ser. B 340, 345-349
41. Alcazar-Roman, A.R. and Wente, S.R. (2008) Inositol polyphosphates: a new frontier for regulating gene expression. Chromosoma 117, 1-13
42. Rando, O.J., Chi, T.H. and Crabtree, G.R. (2003) Second messenger control of chromatin remodeling. Nat. Struct. Biol. 10, 81-83
43. Shen, X., Xiao, H., Ranallo, R., Wu, W.H. and Wu, C. (2003) Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates. Science 299, 112-114
44. Steger, D.J., Haswell, E.S., Miller, A.L., Wente, S.R. and O'Shea, E.K. (2003) Regulation of chromatin remodeling by inositol polyphosphates. Science 299, 114-116
45. Burton, A., Hu, X. and Saiardi, A. (2009) Are inositol pyrophosphates signalling molecules? J. Cell. Physiol. 220, 8-15
46. Pendaries, C., Tronchere, H., Plantavid, M. and Payrastre, B. (2003) Phosphoinositide signaling disorders in human diseases. FEBS Lett. 546, 25-31
47. Chow, C.Y., Zhang, Y., Dowling, J.J., Jin, N., Adamska, M., Shiga, K., Szigeti, K., Shy, M.E., Li, J., Zhang, X. et al. (2007) Mutation of FIG4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature 448, 68-72
48. 2 into PtdIns(5)P by the S. flexneri effector IpgD reorganizes host cell morphology. EMBO J. 21, 5069-5078
49. Downes, C.P., Gray, A., Fairservice, A., Safrany, S.T., Batty, I.H. and Fleming, I. (2005) The regulation of membrane to cytosol partitioning of signalling proteins by phosphoinositides and their soluble headgroups. Biochem. Soc. Trans. 33, 1303-1307
50. Stork, C. and Renshaw, P.F. (2005) Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 10, 900-919
51. 31P-MRS in bipolar disorder. Psychiatry Clin. Neurosci. 58, 82-88
52. Kato, T. and Kato, N. (2000) Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2, 180-190
53. Regenold, W.T., Phatak, P., Marano, C.M., Sassan, A., Conley, R.R. and Kling, M.A. (2009) Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biol. Psychiatry 65, 489-494
54. Konradi, C., Eaton, M., MacDonald, M.L., Walsh, J., Benes, F.M. and Heckers, S. (2004) Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch. Gen. Psychiatry 61, 300-308
55. Cox, J.S. and Walter, P. (1996) A novel mechanism for regulating activity of a transcription factor that controls the unfolded protein response. Cell 87, 391-404
56. Cox, J.S., Chapman, R.E. and Walter, P. (1997) The unfolded protein response coordinates the production of endoplasmic reticulum protein and endoplasmic reticulum membrane. Mol. Biol. Cell 8, 1805-1814
57. Jesch, S.A., Liu, P., Zhao, X., Wells, M.T. and Henry, S.A. (2006) Multiple endoplasmic reticulum-to-nucleus signaling pathways coordinate phospholipid metabolism with gene expression by distinct mechanisms. J. Biol. Chem. 281, 24070-24083
58. Hayashi, A., Kasahara, T., Kametani, M., Toyota, T., Yoshikawa, T. and Kato, T. (2009) Aberrant endoplasmic reticulum stress response in lymphoblastoid cells from patients with bipolar disorder. Int. J. Neuropsychopharmacol. 12, 33-43